Investor Dossier
Sofinnova Partners
active
Typeinvestor
SectorFinTech
LocationParis
Portfolio (29 investments)
Bionyra Pharma
Series A · Jun 2026
€140.0M
Signadori Bio
Seed · May 2026
€11.1M
Mnemo Therapeutics
Series A · Jun 2021
€75.0M
CorWave
Series C · Jan 2021
€35.0M
Home Biosciences
Seed · Nov 2021
€12.8M
PROTERA
Series A · Jul 2021
€8.5M
Meiogenix
Series A · Dec 2021
€11.0M
MicroPEP Technologies
Series A · Jul 2021
€8.5M
Tissium
Series C · Aug 2021
€50.0M
Microphyt
Series B · Nov 2022
€15.0M
Moon surgical
Series A · Jun 2022
€29.7M
Mablink Bioscience
Series A · Oct 2022
€31.0M
Elicit Plant
Series A · Feb 2022
€16.0M
LimFlow SA
Series D · Apr 2022
€36.0M
SafeHeal
Series B · Jan 2022
€40.0M
MicroPEP Technologies
Series A · Jun 2022
€8.8M
Tissium
Series D · May 2023
€49.8M
Gradient Denervation Technologies
Series A · Sept 2023
€13.8M
BrightHeart
Seed · May 2023
LEAD
€2.0M
Amolyt Pharma
Series C · Jan 2023
€128.1M
Moon surgical
Series B · May 2023
€51.2M
Bon Vivant
Seed · Oct 2023
€14.7M
Kiro
Series A · Mar 2023
€13.8M
Elicit Plant
Series B · Nov 2024
€48.0M
Meiogenix
Series A · Dec 2024
—
Cure51
Seed · Mar 2024
€15.0M
May Health
Series B · May 2024
€23.0M
MicroPEP Technologies
Series B · Jul 2024
€27.0M
Bioptimus
Seed · Feb 2024
€35.0M
Funding Lineage
Growth
Apollo (Lead)
—
May 2022